البلد: أستراليا
اللغة: الإنجليزية
المصدر: Department of Health (Therapeutic Goods Administration)
linezolid, Quantity: 600 mg
Cipla Australia Pty Ltd
Linezolid
Tablet, film coated
Excipient Ingredients: magnesium stearate; hyprolose; sodium starch glycollate type A; microcrystalline cellulose; maize starch; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3000
Oral
20, 100
(S4) Prescription Only Medicine
CIPLA LINEZOLID is indicated for the treatment of suspected or proven infections due to Gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant Staphylococcus species and vancomycin resistant Enterococcus species.,CIPLA LINEZOLID is active against Gram-positive bacteria only. ,CIPLA LINEZOLID has no clinical activity against Gram-negative pathogens. Specific Gram-negative therapy is required if a concomitant Gram- negative pathogen is documented or suspected.
Visual Identification: White to off-white, oval shaped, biconvex, film-coated tablets, debossed on one side "CL".; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert
Licence status A
2017-01-24